EICHORCondition: Pulmonary Fibrosis · Sponsor: Bristol-Myers Squibb
The purpose of this study is to evaluate the long-term safety and tolerability of Admilparant in participants who completed participation in parent studies IM027-068 (for idiopathic pulmonary fibrosis (IPF)) and IM027-1015 (for progressive pulmonary fibrosis (PPF)).
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 0113 | Birmingham, Alabama, United States | — |
| Local Institution - 0111 | Ocala, Florida, United States | — |
| Local Institution - 0119 | Philadelphia, Pennsylvania, United States | — |
| Local Institution - 0013 | Florida, Vicente López, Buenos Aires, Argentina | — |
| Local Institution - 0014 | Mar del Plata, Buenos Aires, Argentina | — |
| Local Institution - 0007 | Quilmes, Buenos Aires, Argentina | — |
| Local Institution - 0009 | San Juan Bautista, Buenos Aires, Argentina | — |
| Local Institution - 0003 | Mar del Plata, B, Argentina | — |
| Local Institution - 0001 | Córdoba, Córdoba Province, Argentina | — |
| Local Institution - 0005 | CABA, Distrito Federal, Argentina | — |
| Local Institution - 0002 | Godoy Cruz, Mendoza Province, Argentina | — |
| Local Institution - 0011 | Mendoza, M, Argentina | — |
+ 263 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07441408